期刊文献+

胃癌患者循环肿瘤细胞的检测及临床意义 被引量:15

Detection and clinical significance of circulating tumor cells in patients with gastric cancer
下载PDF
导出
摘要 目的:探讨胃癌患者外周血中循环肿瘤细胞的临床意义。方法:采集45例胃癌患者的外周血,应用密度梯度离心法和免疫荧光法检测外周血中的循环肿瘤细胞(circulating tumor cells,CTCs),并比较其临床病理意义。结果:应用密度梯度离心法和免疫荧光法检测胃癌患者外周血中的CK19阳性肿瘤细胞即为CTCs。45例胃癌患者中27例为CTCs阳性,CTCs阳性与淋巴结转移(P=0.007)、远处转移(P=0.035)和复发密切相关(P=0.035),而与性别、年龄、肿瘤部位和TNM分期、肿瘤分化程度无关(P>0.05)。结论:CTCs与胃癌的不良预后相关。 Objective: To detect circulating tumor cells (CTCs) in patients with gastric cancer and evaluate the relationship among CTCs, clinico-pathological characteristics, and prognosis of gastric cancer. Methods: Peripheral blood samples (10 mL in EDTA) were obtained from 45 patients with gastric cancer. CTCs were detected using density-gradient centrifugation and immunofluo- rescence staining. The clinical significance of the two methods were also compared and investigated. Results: CTC-positive case was defined by the presence of at least one CK19 (+)-CTC per 10 mL of the sample. CTCs were found in 27 of the 45 patients with gastric cancer. The presence of CTCs was significantly correlated with lymph node metastasis, distant metastasis, and recurrence (P=0.007, 0.035, 0.035, respectively). However, CTCs were not significantly correlated with sex, age, tumor location, TNM staging, and tumor differentiation (P〉0.05). Conclusion: CTCs were associated with poor prognosis of gastric cancer.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2014年第22期1442-1445,共4页 Chinese Journal of Clinical Oncology
基金 天津医科大学科技基金项目(编号:2008ky28) 天津市高等学校科技发展基金计划项目(编号:20110130)资助~~
关键词 胃癌 循环肿瘤细胞 CKL9 复发 密度梯度离心法 gastric cancer, circulating tumor cells, CK19, recurrence, density gradient centrifugation
  • 相关文献

参考文献15

  • 1Yu M, Stott S, Toner M, et al. Circulating tumor cells: approaches to isolation and characterization[J].J Cell Biol, 2011, 192(3):373-382.
  • 2Lianidou ES, Markou A. Circulating tumor cells in breast cancer: Detection systems, molecular characterization, and future challenges [J]. Clin Chem, 2011, 57(9):1242-1255.
  • 3Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) de- tection: clinical impact and future directions[J]. Cancer Lett, 2007, 253 (2) :180-204.
  • 4Maheswaran S, Haber DA. Circulating tumor ceUs: a window into cancer biology and metastasis[J]. Curr Opin Genet Dev, 2010, 20 (1): 96-99.
  • 5Cristofanilfi M, Hayes DF, Budd GT, et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast can- cer[J].J Clin Oncol, 2005, 23(7):1420-1430.
  • 6Hayes DF, Cristofanilli M, Budd GT, et al. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-fi'ee and overall survival[J]. Clln Cancer Res, 2006, 129 (14Ptl) :4218-4224.
  • 7Weissenstein U, Schumann A, Reif M, et al. Detection of circulat- ing tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies[J]. BMC Can- cer. 2012.12:206.
  • 8Hong B, Zu Y. Detecting circulating tumor cells: current challenges and new trends[J]. Theranostics, 2013, 3(6):377-394.
  • 9Alix-Panabires C, Pantel K. Circulating tumor cells: liquid biopsy of cancer[J]. Clin Chem, 2013, 59(1):110-118.
  • 10NagTath S, Sequist LV, Maheswaran S, et al. Isolation of rare circu- lating tumour cells in cancer patients by nficrochip technology[J]. Nature, 2007, 450(7173):1235- 1239.

二级参考文献10

  • 1Hou JM, Krebs M, Ward T, et al. Circulating tumor cells as a window on metastasis biology in lung cancer[J]. Am J Pathol, 2011, 178(3) :989-996.
  • 2Jiang Y, Palma JF, Agus DB, et al. Detection of androgen receptor mutations in circulating tumor cells in castration- resistant prostate cancer[J]. Clin Chem, 2010, 56(9):1492- 1495.
  • 3Sandri MT, Zorzino L, Cassatella MC, et al. Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery[J]. Ann Surg Oncol, 2010, 17(6) : 1539-1545.
  • 4Sun YF, Yang XR, Zhou J, et al. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance[J]. J Cancer Res Clin Oncol, 2011,137(8): 1151- 1173.
  • 5Desitter I, Guerrouahen BS, Bena]i-Furet N, et al. A new device for rapid isolation by size and characterization of rare circulating tumor cells[J]. Anticancer Res, 2011, 31 (2): 427-441.
  • 6Lianidou ES, Markou A. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges[J]. Clin Chem, 201 1, 57(9) : 1242-1255.
  • 7Cohen SJ, Alpaugh RK, Gross S, et al. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer[J]. Clin Colorectal Cancer, 2006, 6(2) :125-132.
  • 8Ardyanto TD, Osaki M, Nagahama Y, et al. Down-regulation of cobalt-induced HIF-lalpha expression correlates with cell proliferation and apoptosis in human gastric carcinoma cells[J]. Oncol Rep, 2008,19(2) :339-343.
  • 9Li M, Gu Y, Zhang Z, et al. Vasculogenic mimicry: a new prognostic sign of gastric adenocarcinoma [ J ]. Pathol Oncol Res, 2010, 16(2):259 -266.
  • 10张百红.缺氧导致肿瘤发生的机制[J].国际肿瘤学杂志,2012,39(2):108-110. 被引量:4

同被引文献157

引证文献15

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部